Facebook
Twitter
LinkedIn
ForwardBTF Northwest Women’s Cancer Conference
The “BTF Northwest Women’s Cancer Conference” is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will aim to place the role of different therapeutic agents in the clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.
This women's cancer conference will augment healthcare providers’ foundation of knowledge and clinical competence in the management of women’s cancers.
Target Audience
- Medical Oncologists
- Surgical Oncologists
- Radiation Oncologists
- Gynecological Oncologists
- Oncology Fellows
- Oncology Nurses
- Nurse Practitioners
- Physician Assistants
- Oncology Pharmacists
ORGANIZING COMMITTEE:
Course Director:
Binay Shah, MD, MHA - Binaytara Foundation
Conference Chair:
Fengting Yan, MD - Swedish Health Services
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Discuss the study design and primary endpoints of recently reported and ongoing clinical trials evaluating novel strategies for the management of women’s cancers
- Review frequent molecular abnormalities in women’s cancers, and appropriate timing of testing to detect these abnormalities.
- Integrate emerging evidence in precision oncology into treatment paradigms for the treatment of women’s cancer.
- Compare and contrast the safety and efficacy profiles of novel therapeutic strategies in the management of women’s cancers
September 21st, 2024
All times are listed in Pacific Standard Time (PST)
07:00 AM – 08:00 AM Breakfast, Registration, & Exhibits
08:00 AM – 08:05 AM Welcome
08:05 AM – 08:30 AM Opening Remarks
08:30 AM – 10:00 AM Session 1: Loco-Regional Therapy in Breast Cancer
Session Chair:
08:30 AM – 08.50 AM Breast Cancer Surgery - Angelena Crown, MD
08:50 AM – 09:10 AM Breast Cancer Radiation Oncology - L. Christine Fang, MD
09:10 AM – 10:00 AM Case-Based Discussion
10:00 AM – 10:25 AM Break & Exhibits
10:25 AM – 11:40 AM Session 2: Metastatic Breast Cancer
Session Chair:
10:25 AM – 10:45 AM Updates in the Management of Metastatic Breast Cancer
10:45 AM – 11:40 AM Case-Based Discussion
11:40 AM – 12:40 PM Lunch & Exhibits
12:40 PM – 01:55 PM Session 3: Uterine Cancer
Session Chair:
12:40 PM – 01:00 PM New Therapeutic Strategies in Uterine Cancer
1:00 PM – 01:55 PM Case-Based Discussion
01:55 PM – 03:10 PM Session 4: Cervical Cancer & Ovarian Cancer
Session Chair: Kalyan Banda, MD
01:55 PM – 02:15 PM Ovarian & Cervical Cancer Update - Joshua Press, MD
02:15 PM – 03:10 PM Case-Based Discussion
03:10 PM – 03:15 PM Closing Remarks
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Fengting Yan, MD
L. Christine Fang, M.D.
Joshua Press, MD, MSc
Available Credit
- 5.25 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 5.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 5.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.25 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.